
A new partnership between MSD and Harvard University hopes to combine the expertise of both parties to carve a path …

The multiple sclerosis (MS) drug teriflunomide boosts the effectiveness of cancer drugs in treating glioblastoma, according to researchers from UC, …

AstraZeneca has said its cancer drug Tagrisso significantly improved overall survival in a Phase 3 study of patients with lung …

Roche has said its immunotherapy drug Tecentriq (Atezolizumab), when used in combination with platinum-based chemotherapy, significantly reduced the risk of …

Boehringer Ingelheim has bought Swiss biotech AMAL Therapeutics, a company focused on cancer immunotherapy and cancer vaccines. AMAL’s lead candidate, …

The World Health Organization (WHO) has updated its list of essential medicines to include 28 more drugs. The WHO’s Essential …

Boys in the United Kingdom will from September be given the human papilloma virus (HPV) vaccine, the government has said. …

A new urine test can diagnose cases of aggressive prostate cancer more quickly than invasive biopsies. The test can also …

A strain of the virus that causes the common cold has been found to potentially target, infect and kill cancer …

Cancer deaths cost the US economy $94.4 billion in lifetime earnings in 2015, according to figures from the American Cancer …

Pfizer’s oral poly (ADP-ribose) polymerase (PARP) inhibitor Talzenna (talazoparib) has secured approval in Europe from the European Commission, the drugmaker …

Industry veteran Dr Dietmar Berger has joined Sanofi as the company’s new Global Head of Development. Dr Berger joins the …

British multinational GlaxoSmithKline said on Thursday that it would reintroduce performance-based bonuses for some sales reps in some countries. The …

Japan’s Health Ministry has warned that Eli Lilly’s breast cancer therapy Verzenio could have serious side effects for patient’s lungs. …

MSD has agreed to acquire all outstanding shares in Peloton Therapeutics in a deal worth up to $2.1 billion. US …